| 1 |
Gao J, Zhang S, Li B, Wang Z, Liu W, Zhang L. Sub-Chronic Aluminum Exposure in Rats' Learning-Memory Capability and Hippocampal Histone H4 Acetylation Modification: Effects and Mechanisms. Biol Trace Elem Res 2023. [PMID: 36823489 DOI: 10.1007/s12011-023-03602-6] [Reference Citation Analysis]
|
| 2 |
Hu Y, Liu Z, Xu S, Zhao Q, Liu G, Song X, Qu Y, Qin Y. The interaction between the histone acetyltransferase complex Hat1-Hat2 and transcription factor AmyR provides a molecular brake to regulate amylase gene expression. Mol Microbiol 2023. [PMID: 36760021 DOI: 10.1111/mmi.15036] [Reference Citation Analysis]
|
| 3 |
Wang Q, Liu Z, Cheng X, Wang H, Liang W, Zhu Q, Li P, Gao Y. HAT1 regulates the immune microenvironment and promotes the malignant pathology of lower-grade gliomas.. [DOI: 10.21203/rs.3.rs-2394039/v1] [Reference Citation Analysis]
|
| 4 |
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer. Cancers (Basel) 2022;15. [PMID: 36612223 DOI: 10.3390/cancers15010227] [Reference Citation Analysis]
|
| 5 |
Donnarumma F, Tucci V, Ambrosino C, Altucci L, Carafa V. NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase family. Clin Epigenetics 2022;14:182. [PMID: 36539894 DOI: 10.1186/s13148-022-01402-8] [Reference Citation Analysis]
|
| 6 |
Pansa CC, Molica LR, Moraes KCM. Non-alcoholic fatty liver disease establishment and progression: genetics and epigenetics as relevant modulators of the pathology. Scand J Gastroenterol 2022;:1-13. [PMID: 36426638 DOI: 10.1080/00365521.2022.2148835] [Reference Citation Analysis]
|
| 7 |
Zheng K, Guo L, Ullah S, Cao Y, Huang X, shan H, Jiang J, Wu J, Jiang Y. Proteome changes of sheep rumen epithelium during postnatal development. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1031707] [Reference Citation Analysis]
|
| 8 |
Basha NJ, Basavarajaiah SM. An insight into therapeutic efficacy of heterocycles as histone-modifying enzyme inhibitors that targets cancer epigenetic pathways. Chem Biol Drug Des 2022. [PMID: 36059065 DOI: 10.1111/cbdd.14135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Pogribna M, Word B, Lyn-cook B, Hammons G. Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines. Nanotoxicology. [DOI: 10.1080/17435390.2022.2085206] [Reference Citation Analysis]
|
| 10 |
Douvris A, Viñas J, Burns KD. miRNA-486-5p: signaling targets and role in non-malignant disease. Cell Mol Life Sci 2022;79:376. [PMID: 35731367 DOI: 10.1007/s00018-022-04406-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Song J, Ngo L, Bell K, Zheng YG. Chemoproteomic Profiling of Protein Substrates of a Major Lysine Acetyltransferase in the Native Cellular Context. ACS Chem Biol 2022;17:1092-102. [PMID: 35417122 DOI: 10.1021/acschembio.1c00935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Bakshi K, Nagamalleswari E, Breucker J, Eisenhardt N, Tiwari R, González-prieto R, Fatouros C, Chaugule VK, Lee H, Ilic D, Trulsson F, Mittler G, Vertegaal AC, Pichler A. Multi-level monitoring of EME1-MUS81 in CPT induced nucleolar rDNA repair.. [DOI: 10.1101/2022.04.11.487769] [Reference Citation Analysis]
|
| 13 |
Lu J, He X, Zhang L, Zhang R, Li W. Acetylation in Tumor Immune Evasion Regulation. Front Pharmacol 2021;12:771588. [PMID: 34880761 DOI: 10.3389/fphar.2021.771588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
